Abstract
Allergic contact dermatitis is a delayed-type hypersensitivity reaction mediated by hapten-specific T cells. Many cell types, inflammatory mediators and cytokines are involved in this reaction. Contact hypersensitivity is a self-limited reaction and can be regulated at different levels. Because it is known that disturbances in the immune system underpin the onset of depression and that antidepressant drugs have immunomodulatory effects, it can be hypothesized that antidepressants may have some efficacy in the treatment of contact hypersensitivity. There are some reports on the effectiveness of antidepressants in the inhibition of cutaneous sensitization in mice, and the aim of this narrative review is to assess the evidence for the effectiveness of antidepressant drugs in reducing the recurrence of contact hypersensitivity reactions.
Similar content being viewed by others
References
Ameisen JC, Meade R, Askenase PW: A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. J Immunol, 1989, 142, 3171–3179.
Askenase PW, Majewska-Szczepanik M, Kerfoot S, Szczepanik M: Participation of iNKT cells in the early and late components of Tc1 mediated DNFB contact sensitivity: cooperative role of γδT cells. Scand J Immunol, 2011, 73, 465–467.
Askenase PW, Szczepanik M, Ptak M, Palival V, Ptak W: γδ T cells in normal spleen assist immunized αβ T cells in the adoptive cell transfer of contact sensitivity. Effect of Bordetella pertussis, cyclophosphamide, and antibodies to determinants on suppressor cells. J Immunol, 1995, 154, 3644–3653.
Blauvelt A, Hwang ST, Udey MC: Allergic and immunologic diseases of the skin. J Allergy Clin Immunol, 2003, 111 Suppl 2, 560–570.
Clark RA, Kupper TS: IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood, 2007, 109, 194–202.
Curzytek K, Kubera M, Majewska-Szczepanik M, Szczepanik M, Marcinska K, Ptak W, Duda W et al.: Inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity reaction by antidepressant drugs. Pharmacol Rep, 2013, 65, 1237–1246.
Dey N, Szczepanik M, Lau K, Majewska-Szczepanik M, Askenase PW: Stimulatory lipids accumulate in the mouse liver within 30 minutes of contact sensitization to facilitate activation of naive iNKT cells in a CD1d-dependent fashion. Scand J Immunol, 2011, 74, 52–61.
Diamond M, Kelly JP, Connor TJ: Antidepressants suppress production of the Th1 cytokine interferon-γ, independent of monoamine transporter blockade. EurNeu-ropsychopharmacol, 2006, 16, 481–490.
Diepgen TL, Weisshaar E: Contact dermatitis: epidemiology and frequent sensitizers to cosmetics. J Eur Acad Dermatol Venereol, 2007, 21, Suppl 2, 9–13.
El-Nour H, Lundeberg L, Abdel-Magid N, Lonne-Rahm SB, Azmitia EC, Nordlind K: Serotonergic mechanisms in human allergic contact dermatitis. Acta Derm Venereol, 2007, 87, 390–396.
Fang F, Tang Y, Gao Z, Xu Q: A novel regulatory mechanism of naringenin through inhibition of T lymphocyte function in contact hypersensitivity suppression. Biochem Biophys Res Commun, 2010, 397, 163–169.
Fei M, Wu X, Xu Q: Astilbin inhibits contact hypersensitivity through negative cytokine regulation distinct from cyclosporin A. J Allergy Clin Immunol, 2005, 116, 1350–1356.
Foussat A, Cottrez F, Brun V, Fournier N, Breittmayer JP, Groux H: A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. J Immunol, 2003, 171, 5018–5026.
Gollnick SO, Musser DA, Oseroff AR, Vaughan L, Owczarczak B, Henderson BW: IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response. Photochem Photobiol, 2001, 74, 811–816.
Gorbachev AV, Fairchild RL: CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J Immunol, 2004, 172, 2286–2295.
Griffiths CE, Dearman RJ, Cumberbatch M, Kimber I: Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine, 2005, 32, 67–70.
Harden JL, Egilmez NK: Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest, 2012, 41, 738–764.
Holleran WM, Galardy RE, Gao WN, Levy D, Tang PC, Elias PM: Matrix metalloproteinase inhibitors reduce phorbol ester-induced cutaneous inflammation and hyperplasia. Arch Dermatol Res, 1997, 289, 138–144.
Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav, 2002, 71, 533–554.
Itakura A, Szczepanik M, Campos RA, Paliwal V, Majewska M, Matsuda H, Takatsu K, Askenase PW: An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity. J Immunol, 2005, 175, 7170–7178.
Johnson LA, Jackson DG: Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration. Int Immunol, 2010, 22, 839–849.
Kimber I, Dearman RJ: Allergic contact dermatitis: the cellular effectors. Contact Dermatitis, 2002, 46, 1–5.
Kubera M, Curzytek K, Majewska-Szczepanik M, Szczepanik M, Marcińska K, Ptak W, Leśkiewicz M et al.: Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction. Pharmacol Rep, 2012, 64, 714–722.
Kubera M, Holan V, Mathison R, Maes M: The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocri-nology, 2000, 25, 785–797.
Kubera M, Maes M, Budziszewska B, Basta-Kaim A, Leśkiewicz M, Grygier B, Rogóż Z, Lasoń W: Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood. Pharmacol Rep, 2009, 61, 1105–1112.
Lang UE, Borgwardt S: Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem, 2013, 31, 761–777.
Lee JY, Kim HS, Choi HY, Oh TH, Yune TY: Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury. Brain, 2012, 135, 2375–2389.
Maes M, Song C, Lin A.-H, Bonaccorso S, Kenis G, de Jongh R, Bosmans E, Scharpe S: Negative immu-noregulatory effects of antidepressants: inhibition of interferon-g and stimulation of interleukin-10 secretion. Neuropsychopharmacology, 1999, 20, 370–379.
Majewska M, Szczepanik M: Contact sensitivity reaction, its mechanism and regulation (Polish). Postepy Hig Med Dosw, 2009, 63, 47–57.
Majewska-Szczepanik M, Paust S, von Andrian UH, Askenase PW, Szczepanik M: Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12. Immunology, 2013, 140, 98–110.
Martin SF: T lymphocyte-mediated immune responses to chemical haptens and metal ions: implications for allergic and autoimmune disease. Int Arch Allergy Immunol, 2004, 134, 186–98.
Martin S, Lappin MB, Kohler J, Delattre V, Leicht C, Preckel T, Simon JC, Weltzien HU: Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol, 2000, 115, 260–266.
Martino M, Rocchi G, Escelsior A, Fornaro M: Immuno-modulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance. Curr Neuropharmacol, 2012, 10, 97–123.
Nakae S, Momiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K et al.: Antigen-specific T cel sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity, 2002, 17, 375–387.
O’Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP: A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood, 2006, 107, 1010–1017.
O’Leary JG, Goodarzi M, Drayton DL, von Andrian UH: T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol, 2006, 7, 507–516.
Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, Szczepanik M et al.: Critical role for the che-mokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol, 2010, 11, 1127–1135.
Rudd ML, Nicolas AN, Brown BL, Fischer-Stenger K, Stewart JK: Peritoneal macrophages express the serotonin transporter. J Neuroimmunol, 2005, 159, 113–118.
Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, Wortsman J: Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol, 2003, 196, 144–153.
Suttervala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J et al.: Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity, 2006, 24, 317–327.
Tsuji RF, Szczepanik M, Kawikova I, Palival, V, Campos RA, Akahira-Azuma M, Baumgarth N et al.: B-cell dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med, 2002, 196, 1277–1290.
Wu X, Hsuchou H, Kastin AJ, He Y, Khan RS, Stone KP, Cash MS, Pan W: Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor. Psychoneuroendocrinology, 2011, 36, 266–278.
Yuan XY, Liu W, Zhang P, Wang RY, Guo JY: Effects and mechanisms of aloperine on 2, 4-dinitrofluoro-benzene-induced allergic contact dermatitis in BALB/c mice. Eur J Pharmacol, 2010, 629, 147–152.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Curzytek, K., Kubera, M., Szczepanik, M. et al. Crosstalk between contact hypersensitivity reaction and antidepressant drugs. Pharmacol. Rep 65, 1673–1680 (2013). https://doi.org/10.1016/S1734-1140(13)71529-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1734-1140(13)71529-9